1. Immune evasion in cancer: Mechanistic basis and therapeutic strategies.
   Dass S Vinay et al, 2015, Semin. Cancer Biol. CrossRef
2. Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells
   Dong Hwan Kim et al, 2017 CrossRef
3. Sulforaphane inhibits hypoxia-induced HIF-1α and VEGF expression and migration of human colon cancer cells.
   Dong Hwan Kim et al, 2015, Int J Oncol CrossRef
4. HS-1793, a resveratrol analogue, induces cell cycle arrest and apoptotic cell death in human breast cancer cells.
   Jin-Ah Kim et al, 2014, Int. J. Oncol. CrossRef
5. HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model
   Dong Hwan Kim et al, 2017 CrossRef
6. Effect of Antioxidants Supplementation on Aging and Longevity
   Izabela Sadowska-Bartosz et al, 2014, BioMed Research International CrossRef
7. Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1α/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells.
   Fei Wang et al, 2014, Cancer Sci. CrossRef
8. Prostatakarzinomprophylaxe durch Nahrungsergänzungsmittel
   W. Merkle, 2014, Urologe CrossRef
9. Hypoxia induced microRNA-301b-3p overexpression promotes proliferation, migration and invasion of prostate cancer cells by targeting LRP1B.
   Haiying Zheng et al, 2019, Exp Mol Pathol CrossRef
10. Hypoxia Induces Epithelial-Mesenchymal Transition in Follicular Thyroid Cancer: Involvement of Regulation of Twist by Hypoxia Inducible Factor-1α
    Yeon Ju Yang et al, 2015, Yonsei Med J CrossRef
11. Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis
    Manoj Kumar et al, 2016, Tumor Biol. CrossRef
12. Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia
    Devarajan Nalini et al, 2019, J Cancer Res Clin Oncol CrossRef
13. The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment
    Natalie Silk et al, 2021, JoX CrossRef
14. Hypoxia as a Modulator of Inflammation and Immune Response in Cancer
    Rosa A. Castillo-Rodríguez et al, 2022, Cancers CrossRef
15. HS‑1793 inhibits cell proliferation in lung cancer by interfering with the interaction between p53 and MDM2
    Chungun Lim et al, 2022, Oncol Lett CrossRef
16. Modulation of the ubiquitin‐proteasome system by phytochemicals: Therapeutic implications in malignancies with an emphasis on brain tumors
    Mehdi Sanati et al, 2023, BioFactors CrossRef
17. Resveratrol as sensitizer in colorectal cancer plasticity
    Aranka Brockmueller et al, 2023, Cancer Metastasis Rev CrossRef
18. Loss of LRP1B expression drives acquired chemo and radio-resistance in HPV-positive head and neck cancer
    Mushfiq H. Shaikh et al, 2023, Oral Oncology CrossRef
19. Targeting the prostate tumor microenvironment by plant-derived natural products
    Jiacheng Wu et al, 2023, Cellular Signalling CrossRef
20. Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells
    Cristina Trejo-Solís et al, 2024, Metabolites CrossRef
21. Unveiling the potential of HS-1793: a review of its anticancer properties and therapeutic promise
    Xavier Capó et al, 2024, Future Medicinal Chemistry CrossRef